PLX Protalix BioTherapeutics, Inc.
$2.64▼ -3.30%
Healthcare
Other
After hours
$2.66▲ +0.75%
Sep 11, 5:59 PM ET
Volume 644.6K
Avg Volume (10D) 766.0K
Key Metrics & Fundamentals
Market Cap
$212.71M
P/E Ratio
11.5
Div Yield
–%
52W Range
1.60 - 3.19
% vs 50 MA
8.68%
% vs 200 MA
16.72%
RSI-14
59.3
MACD Histogram
+0.0100
Beta (1Y vs SPY)
1.25
Free Cash Flow
-$10.99M
Gross Rev
$19.90M
Gross Profit
$12.13M
EBITDA
$5.76M
COGS
$7.76M
Operating Exp
$7.46M
Operating Income
$4.67M
EBIT
$4.67M
Pretax Income
$4.86M
Net Income
$3.78M
EPS (Diluted)
0.05
Price & Volume History
Loading chart…
Recent News
Protalix BioTherapeutics to Participate in Upcoming September 2026 Investor Conferences
PR Newswire · Sep 8, 2026 10:45 AM
Protalix BioTherapeutics, Inc. Q2 2026 Earnings Call Summary
Moby · Aug 14, 2026 2:01 AM
PLX: Elfabrio Estimates Up
Zacks Small Cap Research · Aug 13, 2026 5:03 PM
Protalix BioTherapeutics Inc (PLX) (Q2 2026) Earnings Call Highlights: Net Income Surges to $3. ...
GuruFocus.com · Aug 12, 2026 11:04 PM
Protalix: Q2 Earnings Snapshot
Associated Press · Aug 12, 2026 10:58 AM
Protalix BioTherapeutics Reports Second Quarter 2026 Financial and Business Results
PR Newswire · Aug 12, 2026 10:50 AM
Protalix BioTherapeutics to Announce Second Quarter 2026 Financial Results and Business Update on August 12, 2026
PR Newswire · Aug 5, 2026 10:50 AM
Financial Overview - Income Statement
Quarterly
Jun 2026
See PLX's money flow as a full page
Social Sentiment
No Reddit posts found for PLX.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.